Coeptis Therapeutics Holdings, Inc.
COEP
$13.74
$0.0850.62%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 200.70K | 62.90K | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 200.70K | 62.90K | -- | -- | -- |
| Cost of Revenue | 45.20K | 45.20K | -- | -- | -- |
| Gross Profit | 155.50K | 17.70K | -- | -- | -- |
| SG&A Expenses | 4.14M | 3.74M | 1.57M | 1.08M | 2.18M |
| Depreciation & Amortization | 250.00K | 250.00K | 250.00K | 250.00K | 250.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.72M | 4.12M | 2.16M | 2.14M | 2.83M |
| Operating Income | -4.52M | -4.06M | -2.16M | -2.14M | -2.83M |
| Income Before Tax | -4.33M | -3.42M | -3.01M | -1.83M | -3.04M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.33M | -3.42M | -3.01M | -1.83M | -3.04M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 800.00K | 363.20K | 1.06M | -- | -- |
| Net Income | -3.53M | -3.06M | -1.95M | -1.83M | -3.04M |
| EBIT | -4.52M | -4.06M | -2.16M | -2.14M | -2.83M |
| EBITDA | -4.23M | -3.76M | -1.91M | -1.89M | -2.58M |
| EPS Basic | -0.95 | -1.00 | -0.95 | -0.92 | -1.62 |
| Normalized Basic EPS | -0.58 | -0.58 | -0.34 | -0.56 | -1.01 |
| EPS Diluted | -0.95 | -1.00 | -0.95 | -0.92 | -1.62 |
| Normalized Diluted EPS | -0.58 | -0.58 | -0.34 | -0.56 | -1.01 |
| Average Basic Shares Outstanding | 3.71M | 3.07M | 2.05M | 1.99M | 1.88M |
| Average Diluted Shares Outstanding | 3.71M | 3.07M | 2.05M | 1.99M | 1.88M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |